These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2366082

  • 1. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
    Asai A, Shibui S, Barker M, Vanderlaan M, Gray JW, Hoshino T.
    J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082
    [Abstract] [Full Text] [Related]

  • 2. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
    Maeda T, Hoshino T.
    No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
    [Abstract] [Full Text] [Related]

  • 3. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
    Hoshino T, Ito S, Asai A, Shibuya M, Prados MD, Dodson BA, Davis RL, Wilson CB.
    Int J Cancer; 1992 Jan 02; 50(1):1-5. PubMed ID: 1728598
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical double staining with immunogold-silver and alkaline phosphatase to identify nuclear markers of cellular proliferation.
    Shibuya M, Ito S, Davis RL, Hoshino T.
    Biotech Histochem; 1993 Jan 02; 68(1):17-9. PubMed ID: 8383543
    [Abstract] [Full Text] [Related]

  • 5. Cell kinetics of glial tumors.
    Hoshino T.
    Rev Neurol (Paris); 1992 Jan 02; 148(6-7):396-401. PubMed ID: 1448658
    [Abstract] [Full Text] [Related]

  • 6. A new method for analyzing the cell kinetics of human brain tumors by double labeling with bromodeoxyuridine in situ and with iododeoxyuridine in vitro.
    Shibuya M, Ito S, Davis RL, Wilson CB, Hoshino T.
    Cancer; 1993 May 15; 71(10):3109-13. PubMed ID: 8490840
    [Abstract] [Full Text] [Related]

  • 7. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T, Hoshino T.
    No Shinkei Geka; 1984 Aug 15; 12(9):1007-18. PubMed ID: 6390240
    [Abstract] [Full Text] [Related]

  • 8. Double labeling with iodo- and bromodeoxyuridine for cell kinetics studies.
    Shibui S, Hoshino T, Vanderlaan M, Gray JW.
    J Histochem Cytochem; 1989 Jul 15; 37(7):1007-11. PubMed ID: 2659659
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.
    Miller MA, Mazewski CM, Yousuf N, Sheikh Y, White LM, Yanik GA, Hyams DM, Lampkin BC, Raza A.
    J Histochem Cytochem; 1991 Apr 15; 39(4):407-12. PubMed ID: 2005370
    [Abstract] [Full Text] [Related]

  • 10. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MS, Gutin PH, Davis RL, DeArmond SJ.
    J Neurosurg; 1986 Mar 15; 64(3):453-9. PubMed ID: 3950723
    [Abstract] [Full Text] [Related]

  • 11. Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody.
    Nishizaki T, Orita T, Saiki M, Furutani Y, Aoki H.
    J Neurosurg; 1988 Sep 15; 69(3):371-4. PubMed ID: 3404235
    [Abstract] [Full Text] [Related]

  • 12. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
    Danova M, Riccardi A, Gaetani P, Wilson GD, Mazzini G, Brugnatelli S, Buttini R, Butti G, Ucci G, Paoletti P.
    Eur J Cancer Clin Oncol; 1988 May 15; 24(5):873-80. PubMed ID: 3169092
    [Abstract] [Full Text] [Related]

  • 13. Estimation of volume doubling time and cell loss in an experimental rat glioma model in vivo.
    Nakajima M, Nakasu S, Morikawa S, Inubushi T.
    Acta Neurochir (Wien); 1998 May 15; 140(6):607-12; discussion 612-3. PubMed ID: 9755330
    [Abstract] [Full Text] [Related]

  • 14. Impact of IUdR on Rat 9L glioma cell survival for 25-35 keV photon-activated auger electron therapy.
    Alvarez D, Hogstrom KR, Brown TA, Ii KL, Dugas JP, Ham K, Varnes ME.
    Radiat Res; 2014 Dec 15; 182(6):607-17. PubMed ID: 25409122
    [Abstract] [Full Text] [Related]

  • 15. The clinical rationale for S-phase radiosensitization in human tumors.
    McGinn CJ, Kinsella TJ.
    Curr Probl Cancer; 1993 Dec 15; 17(5):273-321. PubMed ID: 8281809
    [Abstract] [Full Text] [Related]

  • 16. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
    Begg AC, Moonen L, Hofland I, Dessing M, Bartelink H.
    Radiother Oncol; 1988 Apr 15; 11(4):337-47. PubMed ID: 3375460
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
    Giordano M, Riccardi A, Danova M, Brugnatelli S, Mazzini G.
    Cancer Detect Prev; 1991 Apr 15; 15(5):391-6. PubMed ID: 1751950
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.